Selective mtDNA mutation accumulation results in beta-cell apoptosis and diabetes development

Area of Science:

• Mitochondrial genetics
• Diabetes research
• Cell biology

Background:

• Accumulation of somatic mitochondrial DNA (mtDNA) mutations is implicated in aging and disease.
• The role of mtDNA mutations in beta-cell dysfunction and diabetes development requires further investigation.

Purpose of the Study:

• To investigate the causal link between somatic mtDNA mutation accumulation and beta-cell loss leading to diabetes.
• To assess the impact of impaired mtDNA proofreading on pancreatic beta-cell function and survival.

Main Methods:

• Generation of transgenic mice expressing a proofreading-deficient mtDNA polymerase-gamma under an insulin promoter.
• Quantification of mtDNA mutations in islets.
• Assessment of glucose tolerance, diabetes prevalence, beta-cell mass, and apoptosis.

Main Results:

• Transgenic mice accumulated mtDNA mutations in islets by 6 weeks of age.
• Significant glucose intolerance and a 52% diabetes prevalence were observed in male transgenic mice.
• Beta-cell mass was reduced, and apoptosis was significantly increased in transgenic mice, correlating with diabetes development.

Conclusions:

• Somatic mtDNA mutation accumulation predisposes mice to beta-cell loss and diabetes.
• Impaired mtDNA proofreading is a potential driver of beta-cell failure and type 2 diabetes.
• mtDNA integrity is crucial for maintaining beta-cell function and preventing diabetes.